Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
Total Debt Over TimeElevated
Percentile Rank100
3Y CAGR+66.7%
5Y CAGR+157.3%
Studio
Year-over-Year Change

Sum of short-term and long-term debt obligations

3Y CAGR
+66.7%/yr
Annual compound
5Y CAGR
+157.3%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
112.7x
Strong expansion
Streak
7 yr
Consecutive growthElevated
PeriodValueYoY Change
2025$93.64M+29.2%
2024$72.45M+139.8%
2023$30.22M+49.5%
2022$20.21M+968.6%
2021$1.89M+127.6%
2020$831000.00+406.7%
2019$164000.00-
2018$0.00-